Central Nervous System News and Research

RSS

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Myelin is an insulating sheath around axons - the processes connecting nerve cells - that is mostly composed of lipids and proteins.

28 Nov 2023

Study identifies how three novel genes cause neurodevelopmental disorders

An international study group led by researchers of Children's Hospital of Philadelphia (CHOP) have identified how three novel genes cause neurodevelopmental disorders.

28 Nov 2023

New cortex organoids more accurately represent the human brain

Essential features of the cortex, an important part of the human brain and its development, are more accurately captured in organoids generated by researchers of the Princess Máxima Center for pediatric oncology and the Hubrecht Institute.

28 Nov 2023

Researchers take step toward developing cell therapy treatment for MS

An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.

27 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.

16 Nov 2023

Does regular cannabis use affect motor skills?

A study in Human Brain Mapping reveals that regular cannabis use alters the neural dynamics of motor control, showing that while cannabis users perform tasks with similar accuracy and reaction time as non-users, their brains exhibit stronger β-ERD responses during task execution, potentially indicating compensatory neural mechanisms.

15 Nov 2023

UMass Lowell researchers study gut microbiome's connection to neurodegenerative diseases

Researchers at UMass Lowell's Zuckerberg College of Health Sciences are exploring how the gut microbiome contributes to the risk of Parkinson's and Alzheimer's diseases.

15 Nov 2023

Senolytics show promise in combating brain aging and COVID-19 neuropathology

Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.

15 Nov 2023

New drug cocktail reverses brain swelling and improves recovery in animal models of brain injury

Cerebral edema, the dangerous brain swelling that occurs after traumatic brain injury (TBI), can increase risk of death tenfold and significantly worsen prospects for recovery in brain function.

15 Nov 2023

Investigating the link between gut inflammation, aging, and Alzheimer's disease

A recent study in discusses how gut inflammation is associated with age and Alzheimer's disease.

15 Nov 2023

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson's disease (PD).

15 Nov 2023

New research explores the unique effects of ADHD medications on Drosophila brain cells

The effect of two drugs used for the treatment of attention-deficit/hyperactivity disorder.

15 Nov 2023

Drinking coffee regularly may help prevent irritable bowel syndrome

Study reveals that coffee consumption is associated with a reduced risk of developing irritable bowel syndrome (IBS), as determined by a systematic review and meta-analysis of global studies.

14 Nov 2023

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

In a JAMA Network Open study, researchers found no evidence of neuroinflammation or blood-brain barrier dysfunction in cerebrospinal fluid markers of individuals with post-COVID-19 condition and neuropsychiatric symptoms compared to controls. The study, which assessed cytokines, chemokines, and neuroinflammation markers, suggests that persistent central nervous system immune activation may not be the primary driver of neurological long COVID symptoms.

13 Nov 2023

Central Nervous System News and Research

Abnormal myelin, not loss of myelin, may drive axon degeneration in myelin diseases

Study identifies how three novel genes cause neurodevelopmental disorders

New cortex organoids more accurately represent the human brain

Researchers take step toward developing cell therapy treatment for MS

Pigeon virus causes fatal neurological disease in young leukemia patient

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Does regular cannabis use affect motor skills?

UMass Lowell researchers study gut microbiome's connection to neurodegenerative diseases

Senolytics show promise in combating brain aging and COVID-19 neuropathology

New drug cocktail reverses brain swelling and improves recovery in animal models of brain injury

Investigating the link between gut inflammation, aging, and Alzheimer's disease

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease

New research explores the unique effects of ADHD medications on Drosophila brain cells

Drinking coffee regularly may help prevent irritable bowel syndrome

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran

How do sex hormones and birth control affect brain fear circuits?

New prodrug approach enhances drug delivery to brain cells

Study shows linear associations between body mass index and site-specific tumors in young males

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News